Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAZNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAZNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAZNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.26NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.25NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.4.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.4.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.4.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BL.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.47NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.47NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
ED.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
ED.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ED.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CQ.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CQ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CQ.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used